Trial
NCT01266785
Infliximab, Regulatory T Cells, IL2 and Crohn's Disease
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Oregon Health and Science University
Collaborators
Centocor, Inc.
Condition
Crohn's Disease
Intervention
Infliximab
Why stopped
Lack of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-08